Evidence-Based Medicine Guidelines
Desferrioxamine mesylate for iron overload in transfusion-dependent thalassaemia
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Desferrioxamine Mesylate for Iron Overload in Transfusion-dependent Thalassaemia." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/454380/all/Desferrioxamine_mesylate_for_iron_overload_in_transfusion_dependent_thalassaemia.
Desferrioxamine mesylate for iron overload in transfusion-dependent thalassaemia. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/454380/all/Desferrioxamine_mesylate_for_iron_overload_in_transfusion_dependent_thalassaemia. Accessed November 30, 2023.
Desferrioxamine mesylate for iron overload in transfusion-dependent thalassaemia. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/454380/all/Desferrioxamine_mesylate_for_iron_overload_in_transfusion_dependent_thalassaemia
Desferrioxamine Mesylate for Iron Overload in Transfusion-dependent Thalassaemia [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2023 November 30]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/454380/all/Desferrioxamine_mesylate_for_iron_overload_in_transfusion_dependent_thalassaemia.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Desferrioxamine mesylate for iron overload in transfusion-dependent thalassaemia
ID - 454380
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/454380/all/Desferrioxamine_mesylate_for_iron_overload_in_transfusion_dependent_thalassaemia
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
